Cambiar Investors’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,052,401
Closed -$26.2M 146
2022
Q2
$26.2M Sell
1,052,401
-311,473
-23% -$9.31M 1.17% 45
2022
Q1
$45.9M Buy
1,363,874
+210,819
+18% +$6.93M 1.73% 27
2021
Q4
$37.4M Sell
1,153,055
-122,698
-10% -$4.04M 1.28% 38
2021
Q3
$44.6M Sell
1,275,753
-62,842
-5% -$2.46M 1.53% 29
2021
Q2
$55.6M Sell
1,338,595
-211,652
-14% -$8.46M 1.79% 18
2021
Q1
$57.2M Buy
+1,550,247
New +$58.6M 1.99% 12
2018
Q4
Sell
-38,388
Closed -$1.97M 176
2018
Q3
$1.97M Buy
38,388
+629
+2% +$31.5K 0.04% 144
2018
Q2
$1.9M Buy
37,759
+10,357
+38% +$525K 0.03% 143
2018
Q1
$1.4M Sell
27,402
-2,549
-9% -$136K 0.02% 138
2017
Q4
$1.57M Sell
29,951
-2,665,763
-99% -$132M 0.02% 140
2017
Q3
$132M Buy
2,695,714
+99,234
+4% +$4.72M 2.07% 16
2017
Q2
$125M Buy
2,596,480
+80,064
+3% +$3.69M 1.97% 14
2017
Q1
$106M Buy
2,516,416
+188,019
+8% +$7.77M 1.77% 15
2016
Q4
$98.3M Sell
2,328,397
-55,287
-2% -$2.26M 1.69% 12
2016
Q3
$104M Buy
2,383,684
+49,951
+2% +$2.24M 1.52% 18
2016
Q2
$102M Buy
2,333,733
+114,840
+5% +$4.95M 1.44% 16
2016
Q1
$97.8M Buy
+2,218,893
New +$94M 1.4% 19

Other funds holding FMS

Cambiar Investors's FMS Position: Q3 2022 in Review

Cambiar Investors sold out of Fresenius Medical Care (FMS) in Q3 2022, closing a stake of 1,052,401 shares — an estimated $26.2M sold.

Cambiar Investors first reported a position in FMS in Q1 2016 and held it in 17 quarters. The position peaked at $132M in Q3 2017. 141 funds tracked by Wall St. Rank hold FMS as of Q3 2022.

  • Cambiar Investors reported no remaining Fresenius Medical Care position as of Q3 2022 after selling out during the quarter.
  • Cambiar Investors sold 1,052,401 Fresenius Medical Care shares in Q3 2022, an estimated $26.2M.
  • Cambiar Investors first reported a position in Fresenius Medical Care in Q1 2016 and held it in 17 quarters.
  • Cambiar Investors's Fresenius Medical Care position peaked at $132M in Q3 2017.
  • 141 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q3 2022.

Based on Cambiar Investors's 13F filing for Q3 2022, filed 28 Oct 2022.